Terms: = Brain cancer AND XPO1, DKFZp686B1823, 7514, ENSG00000082898, O14980, CRM1
29 results:
1. Risk factors for amputation in diabetic foot ulcers: A retrospective analysis.
Zhang X; Li Q; Zhou X; Xu Y; Shu Z; Deng H
Int Wound J; 2024 Apr; 21(4):e14832. PubMed ID: 38546034
[TBL] [Abstract] [Full Text] [Related]
2. The efficacy of selinexor (KPT-330), an xpo1 inhibitor, on non-hematologic cancers: a comprehensive review.
Landes JR; Moore SA; Bartley BR; Doan HQ; Rady PL; Tyring SK
J Cancer Res Clin Oncol; 2023 May; 149(5):2139-2155. PubMed ID: 35941226
[TBL] [Abstract] [Full Text] [Related]
3. Molecular Genetics and Targeted Therapies for Paediatric High-grade Glioma.
Rallis KS; George AM; Wozniak AM; Bigogno CM; Chow B; Hanrahan JG; Sideris M
Cancer Genomics Proteomics; 2022; 19(4):390-414. PubMed ID: 35732328
[TBL] [Abstract] [Full Text] [Related]
4. A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma.
Lassman AB; Wen PY; van den Bent MJ; Plotkin SR; Walenkamp AME; Green AL; Li K; Walker CJ; Chang H; Tamir S; Henegar L; Shen Y; Alvarez MJ; Califano A; Landesman Y; Kauffman MG; Shacham S; Mau-Sørensen M
Clin Cancer Res; 2022 Feb; 28(3):452-460. PubMed ID: 34728525
[TBL] [Abstract] [Full Text] [Related]
5. Palmdelphin Regulates Nuclear Resilience to Mechanical Stress in the Endothelium.
Sáinz-Jaspeado M; Smith RO; Plunde O; Pawelzik SC; Jin Y; Nordling S; Ding Y; Aspenström P; Hedlund M; Bastianello G; Ascione F; Li Q; Demir CS; Fernando D; Daniel G; Franco-Cereceda A; Kroon J; Foiani M; Petrova TV; Kilimann MW; Bäck M; Claesson-Welsh L
Circulation; 2021 Nov; 144(20):1629-1645. PubMed ID: 34636652
[TBL] [Abstract] [Full Text] [Related]
6. Bench to bedside radiosensitizer development strategy for newly diagnosed glioblastoma.
Degorre C; Tofilon P; Camphausen K; Mathen P
Radiat Oncol; 2021 Sep; 16(1):191. PubMed ID: 34583727
[TBL] [Abstract] [Full Text] [Related]
7. Repolarization of tumor infiltrating macrophages and increased survival in mouse primary CNS lymphomas after xpo1 and BTK inhibition.
Jiménez I; Carabia J; Bobillo S; Palacio C; Abrisqueta P; Pagès C; Nieto JC; Castellví J; Martínez-Ricarte F; Escoda L; Perla C; Céspedes Torrez DH; Boix J; Purroy N; Puigdefàbregas L; Seoane J; Bosch F; Crespo M
J Neurooncol; 2020 Aug; 149(1):13-25. PubMed ID: 32691208
[TBL] [Abstract] [Full Text] [Related]
8. YAP promotes the proliferation of neuroblastoma cells through decreasing the nuclear location of p27
Shen X; Xu X; Xie C; Liu H; Yang D; Zhang J; Wu Q; Feng W; Wang L; Du L; Xuan L; Meng C; Zhang H; Wang W; Wang Y; Xie T; Huang Z
Cell Prolif; 2020 Feb; 53(2):e12734. PubMed ID: 31863533
[TBL] [Abstract] [Full Text] [Related]
9. Simultaneous targeting of xpo1 and BCL2 as an effective treatment strategy for double-hit lymphoma.
Liu Y; Azizian NG; Dou Y; Pham LV; Li Y
J Hematol Oncol; 2019 Nov; 12(1):119. PubMed ID: 31752970
[TBL] [Abstract] [Full Text] [Related]
10. xpo1 inhibitor KPT-330 synergizes with Bcl-xL inhibitor to induce cancer cell apoptosis by perturbing rRNA processing and Mcl-1 protein synthesis.
Zhu ZC; Liu JW; Yang C; Zhao M; Xiong ZQ
Cell Death Dis; 2019 May; 10(6):395. PubMed ID: 31113936
[TBL] [Abstract] [Full Text] [Related]
11. Dual Inhibition of Bcl-2/Bcl-xL and xpo1 is synthetically lethal in glioblastoma model systems.
Shang E; Zhang Y; Shu C; Ishida CT; Bianchetti E; Westhoff MA; Karpel-Massler G; Siegelin MD
Sci Rep; 2018 Oct; 8(1):15383. PubMed ID: 30337641
[TBL] [Abstract] [Full Text] [Related]
12. A comparative analysis of clinicopathological features and survival among early adolescents/young adults and children with low-grade glioma: a report from the Children's Oncology Group.
Margol AS; Yeo KK; Xia C; Onar A; Robison NJ; Freyer DR; Dhall G
J Neurooncol; 2018 Dec; 140(3):575-582. PubMed ID: 30173409
[TBL] [Abstract] [Full Text] [Related]
13. Detection of circulating tumour cell clusters in human glioblastoma.
Krol I; Castro-Giner F; Maurer M; Gkountela S; Szczerba BM; Scherrer R; Coleman N; Carreira S; Bachmann F; Anderson S; Engelhardt M; Lane H; Evans TRJ; Plummer R; Kristeleit R; Lopez J; Aceto N
Br J Cancer; 2018 Aug; 119(4):487-491. PubMed ID: 30065256
[TBL] [Abstract] [Full Text] [Related]
14. The xpo1 Inhibitor Selinexor Inhibits Translation and Enhances the Radiosensitivity of Glioblastoma Cells Grown
Wahba A; Rath BH; O'Neill JW; Camphausen K; Tofilon PJ
Mol Cancer Ther; 2018 Aug; 17(8):1717-1726. PubMed ID: 29866745
[TBL] [Abstract] [Full Text] [Related]
15. A novel magnetic resonance imaging segmentation technique for determining diffuse intrinsic pontine glioma tumor volume.
Singh R; Zhou Z; Tisnado J; Haque S; Peck KK; Young RJ; Tsiouris AJ; Thakur SB; Souweidane MM
J Neurosurg Pediatr; 2016 Nov; 18(5):565-572. PubMed ID: 27391980
[TBL] [Abstract] [Full Text] [Related]
16. Identifying candidate genes for 2p15p16.1 microdeletion syndrome using clinical, genomic, and functional analysis.
Bagheri H; Badduke C; Qiao Y; Colnaghi R; Abramowicz I; Alcantara D; Dunham C; Wen J; Wildin RS; Nowaczyk MJ; Eichmeyer J; Lehman A; Maranda B; Martell S; Shan X; Lewis SM; O'Driscoll M; Gregory-Evans CY; Rajcan-Separovic E
JCI Insight; 2016 Mar; 1(3):e85461. PubMed ID: 27699255
[TBL] [Abstract] [Full Text] [Related]
17. KPT-8602, a second-generation inhibitor of xpo1-mediated nuclear export, is well tolerated and highly active against AML blasts and leukemia-initiating cells.
Etchin J; Berezovskaya A; Conway AS; Galinsky IA; Stone RM; Baloglu E; Senapedis W; Landesman Y; Kauffman M; Shacham S; Wang JC; Look AT
Leukemia; 2017 Jan; 31(1):143-150. PubMed ID: 27211268
[TBL] [Abstract] [Full Text] [Related]
18. Complications Following Stereotactic Needle Biopsy of Intracranial Tumors.
Malone H; Yang J; Hershman DL; Wright JD; Bruce JN; Neugut AI
World Neurosurg; 2015 Oct; 84(4):1084-9. PubMed ID: 26008141
[TBL] [Abstract] [Full Text] [Related]
19. Characteristics of 2p15-p16.1 microdeletion syndrome: Review and description of two additional patients.
Shimojima K; Okamoto N; Yamamoto T
Congenit Anom (Kyoto); 2015 Aug; 55(3):125-32. PubMed ID: 25900130
[TBL] [Abstract] [Full Text] [Related]
20. Preclinical antitumor efficacy of selective exportin 1 inhibitors in glioblastoma.
Green AL; Ramkissoon SH; McCauley D; Jones K; Perry JA; Hsu JH; Ramkissoon LA; Maire CL; Hubbell-Engler B; Knoff DS; Shacham S; Ligon KL; Kung AL
Neuro Oncol; 2015 May; 17(5):697-707. PubMed ID: 25366336
[TBL] [Abstract] [Full Text] [Related]
[Next]
